Opendata, web and dolomites

CLINICOVERY SIGNED

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CLINICOVERY project word cloud

Explore the words cloud of the CLINICOVERY project. It provides you a very rough idea of what is the project "CLINICOVERY" about.

physiological    trials    outputs    2024    upgrades    ema    public    adverse    edc    price    multiple    million    pharmaceutical    entities    2015    contains    45    warning    monitoring    patient    fda    chemical    quantum    participating    clinicovery    least    profit    expenses    cloud    99    16    health    versatile    roi    gives    maintenance    propelled    biomedical    company    endpoints    electronic    pencil    remarkable    burden    cagr    clinical    approval    accumulative    administrative    gains    33    create    compliance    capability    regulatory    paper    platform    pacific    returns    time    stakeholders    yields    faster    reduce    generating    market    effect    huge    agencies    2020    economic    less    region    commercial    highest    travels    international    markets    investment    modalities    healthy    sectors    asia    provides    complicate    jobs    rate    detect    performing    disease    countries    private    capture    industry    obtaining    data    medical    workforce   

Project "CLINICOVERY" data sheet

The following table provides information about the project.

Coordinator
APPLOADING SL 

Organization address
address: C/ ISAAC NEWTON, S/N, EDIFICIO DISSET MOD C10 PARC
city: PALMA DE MALLORCA
postcode: 7121
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://apploading.com Isaac Newton street
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-04-01   to  2018-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    APPLOADING SL ES (PALMA DE MALLORCA) coordinator 50˙000.00

Map

 Project objective

The biomedical research is the key to reduce disease burden, and yields economic returns both through improved health gains (a healthy workforce) and through commercial exploitation of research outputs. The increasing disease burden has propelled the pharmaceutical industry to bring up new chemical entities into the market at a higher rate, increasing the number of clinical trials and generating huge quantum of clinical data. As a result, clinical trials are becoming increasingly complex, due the use of multiple data capture modalities (paper and pencil or/and Electronic Data Capture systems (EDC)), which require long implementation time, maintenance, upgrades and high economic investment, the need to evaluate more study endpoints and regulatory compliance with Medical Agencies and the growing number of stakeholders participating in the study. With CLINICOVERY, we will contribute to promote biomedical research in all the target sectors (Public and private) providing a versatile, regulatory compliance (FDA and EMA) cloud based platform that will reduce the implementation time (99%less) and costs (monitoring, price, travels, administrative expenses) and provides the capability to manage a huge and complicate data in large and international clinical trials to reach a faster market approval. Moreover, will be the unique platform in the market that contains a system to detect physiological patient data which gives advance warning of an adverse effect. The exploitation of the CLINICOVERY project will reach the EU countries, as the second region performing more clinical trials and then the Asia Pacific region, with the highest market growth (CAGR around 16% between 2015-2020) and US. In this way, the CLINICOVERY project will not only have a remarkable economic impact on our company (obtaining €7.33 million accumulative profit and ROI of 4.2 and create at least 45 new jobs by 2024), but will also contribute to increase our international presence, by targeting new markets.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLINICOVERY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLINICOVERY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More